{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:11:49Z","timestamp":1790007109103,"version":"4.0.1"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,5,9]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The healthcare community recognises the need for lower emission inhaler options; however, in the UK, most inhalers prescribed are pressurised metered dose inhalers (pMDIs) despite dry powder inhalers (DPIs) having a markedly lower carbon footprint as they do not contain propellants. For this reason, UK clinicians have been encouraged to offer switches from pMDIs to DPIs where feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using data from the Asthma+Lung UK\u2019s\n                      <jats:italic>\u2018Life with a Lung Condition\u2019<\/jats:italic>\n                      2023 online survey, demographic, economic and clinical factors were analysed to determine who had and had not been offered a switch; whose switch had been successful and why some respondents chose not to switch.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>9960 people with asthma responded (77.9% female; age 59.9\u00b113.0) and 7059 (87.7%) were pMDI users. The 3753 (53.2%) who were offered a pMDI to DPI switch had a greater awareness of lower-emission inhaler options (72% vs 53.2%*), uncontrolled asthma (61% vs 54.1%*), and had required unscheduled healthcare (27.4% vs 21.2%*) or &gt;2 courses oral corticosteroids (27.6% vs 21.6%*) in the last year (all *p&lt;0.001). 432 (11.5%) opted not to change inhaler when offered. 3321 (88.5%) accepted the switch and it was successful in 2126 (64%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In a large UK survey of people with asthma, over half of those on pMDIs had been offered a switch. It was successful in most who attempted it but unsuccessful switches were associated with subjective and objective markers of poor disease control. Some patients decline the switch because they like their pMDI, but some have ongoing concerns about the efficacy and safety of a DPI and is most feasible when integrated into routine reviews for patients with stable disease, alongside ongoing efforts to optimise asthma outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002749","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:55:23Z","timestamp":1790006123000},"page":"e002749","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Sustainable asthma inhalers: who is offered the option to change, who declines and who successfully switches?"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-0232","authenticated-orcid":false,"given":"Laura","family":"Piggott","sequence":"first","affiliation":[{"name":"Trinity College, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cumella","sequence":"additional","affiliation":[{"name":"Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Francis","sequence":"additional","affiliation":[{"name":"Asthma + Lung UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Walker","sequence":"additional","affiliation":[{"name":"Asthma + Lung UK, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kent","sequence":"additional","affiliation":[{"name":"Trinity College, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1936-6769","authenticated-orcid":false,"given":"Grainne","family":"d\u2019Ancona","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"2026092108551388000_13.1.e002749.1","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention. 2024. Available: https:\/\/ginasthma.org\/wp-content\/uploads\/2024\/05\/GINA-2024-Strategy-Report-24_05_22_WMS.pdf"},{"key":"2026092108551388000_13.1.e002749.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4680","article-title":"Respiratory disease mortality in the United Kingdom compared with EU15+ countries in 1985-2015: observational study","volume":"363","author":"Salciccioli","year":"2018","journal-title":"BMJ"},{"key":"2026092108551388000_13.1.e002749.3","unstructured":"International Respiratory Coalition . Data from the UK by disease. n.d. Available: https:\/\/international-respiratory-coalition.org\/countries\/uk"},{"key":"2026092108551388000_13.1.e002749.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f3359","article-title":"Inhaled drugs and global warming: time to shift to dry powder inhalers","volume":"346","author":"Hillman","year":"2013","journal-title":"BMJ"},{"key":"2026092108551388000_13.1.e002749.5","first-page":"128","volume-title":"Montreal protocol on substances that deplete the ozone layer","volume":"26","year":"1987"},{"key":"2026092108551388000_13.1.e002749.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028763","article-title":"Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England","volume":"9","author":"Wilkinson","year":"2019","journal-title":"BMJ Open"},{"key":"2026092108551388000_13.1.e002749.7","unstructured":"British Thoracic Society . Position statement sustainability and the environment: climate change & lung health. 2024. Available: https:\/\/www.brit-thoracic.org.uk\/document-library\/governance-and-policy-documents\/position-statements\/position-statement-on-sustainability-and-the-environment-climate-change-lung-health-2024\/"},{"key":"2026092108551388000_13.1.e002749.8","unstructured":"European Respiratory Society . Position statement on asthma and the environment. 2021. Available: https:\/\/www.ersnet.org\/wp-content\/uploads\/2024\/01\/ERS-position-statement-on-asthma-and-the-environment-5-May-2021.pdf"},{"key":"2026092108551388000_13.1.e002749.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60931-X."},{"key":"2026092108551388000_13.1.e002749.10","unstructured":"Montreal Protocol on Substances That Deplete the Ozone Layer Medical and Chemical Technical Options committee . 2018 assessment report. 2018. Available: https:\/\/ozone.unep.org\/sites\/default\/files\/2019-04\/MCTOC-Assessment-Report-2018.pdf [Accessed 10 Sep 2025]."},{"key":"2026092108551388000_13.1.e002749.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-218088"},{"key":"2026092108551388000_13.1.e002749.12","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2023.2179984"},{"key":"2026092108551388000_13.1.e002749.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.03.012"},{"key":"2026092108551388000_13.1.e002749.14","unstructured":"National Health Service (NHS) . Delivering a \u2018net zero\u2019 national health service. 2020. Available: https:\/\/www.england.nhs.uk\/greenernhs\/wp-content\/uploads\/sites\/51\/2020\/10\/delivering-a-net-zero-national-health-service.pdf"},{"key":"2026092108551388000_13.1.e002749.15","unstructured":"National Health Service (NHS) England . Network contract directed enhanced service \u2013 contract specification 2022\/23 \u2013 primary care network requirements and entitlements. 2022. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2022\/03\/B1963_i_Network-Contract-DES-Specification_171022.pdf"},{"key":"2026092108551388000_13.1.e002749.16","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0222-2022","article-title":"Climate change and respiratory disease: clinical guidance for healthcare professionals","volume":"19","author":"Andersen","year":"2023","journal-title":"Breathe (Sheff)"},{"key":"2026092108551388000_13.1.e002749.17","article-title":"The sustainability agenda and inhaled therapy: what do patients want?","volume":"58","author":"D\u2019Ancona","year":"2021","journal-title":"Eur Resp J"},{"key":"2026092108551388000_13.1.e002749.18","unstructured":"National Institute for Health and Care Excellence (NICE) . Asthma inhalers and climate change: decision aid. 2022. Available: https:\/\/www.nice.org.uk\/guidance\/ng80\/resources\/inhalers-for-asthma-patient-decision-aid-pdf-6727144573"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:55:28Z","timestamp":1790006128000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,21]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjresp-2024-002749"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002749","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}